Dana M. Clausen

In Vitro Cytotoxicity and In Vivo Efficacy, Pharmacokinetics, and Metabolism of 10074-G5, a Novel Small-Molecule Inhibitor of c-Myc/Max Dimerization

Dana M. Clausen, Jianxia Guo, Robert A. Parise et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 114 citations · Full text

Medicine, Oncology, Pharmacology +15

A Cell-Targeted Photodynamic Nanomedicine Strategy for Head and Neck Cancers

Anthony S. Malamas, Rachna Solanki, Dana M. Clausen et al. · Molecular Pharmaceutics · 2013 · 64 citations

Pharmacy, Oncology, Pharmacology +17

Intracellular metalloprotease activity controls intraneuronal Aβ aggregation and limits secretion of Aβ <i>via</i> exosomes

Javier Pacheco‐Quinto, Dana M. Clausen, Rocío Pérez‐González et al. · The FASEB Journal · 2018 · 43 citations

Life Sciences, Neurobiology, Neuroscience +17

In vitro cytotoxicity, pharmacokinetics, tissue distribution, and metabolism of small-molecule protein kinase D inhibitors, kb-NB142-70 and kb-NB165-09, in mice bearing human cancer xenografts

Jianxia Guo, Dana M. Clausen, Jan H. Beumer et al. · Cancer Chemotherapy and Pharmacology · 2012 · 25 citations

Medicine, Pharmacokinetics, Pharmacology +12

Specificity and Diagnostic Utility of Cerebrospinal Fluid CXCL13 in Lyme Neuroborreliosis

Elizabeth A. Eckman, Dana M. Clausen, Aimee Herdt et al. · Clinical Infectious Diseases · 2020 · 25 citations

Veterinary Medicine, Infectious Diseases, Neurology +17